Dual targeting of Aurora Kinase A and poly (ADP-ribose) polymerase as a therapeutic option for patients with ovarian cancer: preclinical evaluations

20250 citationsJournal Articlegold Open Access

Authors

Our studies indicate a synergistic benefit from combined PARPi and AURKAi in mutant and wild-type BRCA EOC tumors.

Good health and well-being

Published in: Journal of Cancer Research and Clinical Oncology

Volume 151, Issue 3, pp. 124-124

Field-Weighted Citation Impact: 0.00